Comparison of acute and late toxicity of two regimens of 3- and 5-week concomitant boost prone IMRT to standard 6-week breast radiotherapy

Frontiers in Oncology

Volumn 2 MAY, Issue , 2012, Pages

  Raza, Shahzad ^a   Lymberis, Stella C ^a   Ciervide, Raquel ^a   Axelrod, Deborah ^a   Fenton Kerimian, Maria ^a   Magnolfi, Chiara ^a   Rosenstein, Barry ^a   DeWyngaert, J Keith ^a   Formenti, Silvia C ^a  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Acute and late toxicity; Breast cancer; Radiation therapy

Indexed keywords

ADULT; ARTICLE; BREAST CANCER; CANCER CONTROL; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; DERMATITIS; DESQUAMATION; EDEMA; ERYTHEMA; FATIGUE; FIBROSIS; FOLLOW UP; HUMAN; HYPERPIGMENTATION; INTENSITY MODULATED RADIATION THERAPY; MAJOR CLINICAL STUDY; MASTALGIA; RADIATION DOSE; RADIATION DOSE FRACTIONATION; SCORING SYSTEM; TELANGIECTASIA;

EID: 84885421333     PISSN: None     EISSN: 2234943X     Source Type: Journal    
DOI: 10.3389/fonc.2012.00044     Document Type: Article

References (30)

1. Archambeau, J. O., Pezner, R., and Wasserman, T. (1995). Pathophysiology of irradiated skin and breast. Int. J. Radiat. Oncol. Biol. Phys. 31, 1171-1185.
2. Bartelink, H., Horiot, J. C., Poortmans, P., Struikmans, H., Van Den Bogaert, W., Barillot, I., Fourquet, A., Borger, J., Jager, J., Hoogenraad, W., Collette, L., and Pierart, M. (2001). Recurrence rates after treatment of breast cancer with standard radiotherapy with or without additional radiation. N. Engl. J. Med. 345, 1378-1387.
3. Bentzen, S. M., Agrawal, R. K., Aird, E. G., Barrett, J. M., Barrett-Lee, P. J., Bliss, J. M., Brown, J., Dewar, J. A., Dobbs, H. J., Haviland, J. S., Hoskin, P. J., Hopwood, P., Lawton, P. A., Magee, B. J., Mills, J., Morgan, D. A., Owen, J. R., Simmons, S., Sumo, G., Sydenham, M. A., Venables, K., and Yarnold, J. R. (2008). The UK Standardisation of Breast Radiotherapy (START) Trial A of radiotherapy hypofractionation for treatment of early breast cancer: a randomised trial. Lancet Oncol. 9, 331-341.
4. Croog, V. J., Wu, A. J., McCormick, B., and Beal, K. P. (2009). Accelerated whole breast irradiation with intensity-modulated radiotherapy to the prone breast. Int. J. Radiat. Oncol. Biol. Phys. 73, 88-93.
5. Darby, S., Mcgale, P., Correa, C., Taylor, C., Arriagada, R., Clarke, M., Cutter, D., Davies, C., Ewertz, M., Godwin, J., Gray, R., Pierce, L., Whelan, T., Wang, Y., and Peto, R. (2011). Effect of radiotherapy after breast-conserving surgery on 10-year recurrence and 15-year breast cancer death: meta-analysis of individual patient data for 10,801 women in 17 randomised trials. Lancet 378, 1707-1716.
6. DeWyngaert, J. K., Jozsef, G., Mitchell, J., Rosenstein, B., and Formenti, S. C. (2007). Accelerated intensity-modulated radiotherapy to breast in prone position: dosimetric results. Int. J. Radiat. Oncol. Biol. Phys. 68, 1251-1259.
7. Formenti, S. C., Gidea-Addeo, D., Goldberg, J. D., Roses, D. F., Guth, A., Rosenstein, B. S., and Dewyngaert, K. J. (2007). Phase I-II trial of prone accelerated intensity modulated radiation therapy to the breast to optimally spare normal tissue. J. Clin. Oncol. 25, 2236-2242.
8. Fowler, J. F. (1989). The linear-quadratic formula and progress in fractionated radiotherapy. Br. J. Radiol. 62, 679-694.
9. Freedman, G. M., Anderson, P. R., Goldstein, L. J., Ma, C. M., Li, J., Swaby, R. F., Litwin, S., Watkins-Bruner, D., Sigurdson, E. R., and Morrow, M. (2007). Four-week course of radiation for breast cancer using hypofractionated intensity modulated radiation therapy with an incorporated boost. Int. J. Radiat. Oncol. Biol. Phys. 68, 347-353.
10. Haustermans, K., Fowler, J., Geboes, K., Christiaens, M. R., Lerut, A., and Van Der Schueren, E. (1998). Relationship between potential doubling time (Tpot), labeling index and duration of DNA synthesis in 60 esophageal and 35 breast tumors: is it worthwhile to measure Tpot? Radiother. Oncol. 46, 157-167.
11. Hoeller, U., Tribius, S., Kuhlmey, A., Grader, K., Fehlauer, F., and Alberti, W. (2003). Increasing the rate of late toxicity by changing the score? A comparison of RTOG/EORTC and LENT/SOMA scores. Int. J. Radiat. Oncol. Biol. Phys. 55, 1013-1018.
12. Huppert, N., Jozsef, G., Dewyngaert, J. K., and Formenti, S. C. (2011). The role of a prone setup in breast radiation therapy. Front. Radiat. Ther. Oncol. 1, 1-8.
13. Jalali, R., Malde, R., Bhutani, R., Budrukkar, A., Badwe, R., and Sarin, R. (2008). Prospective evaluation of concomitant tumour bed boost with whole breast irradiation in patients with locally advanced breast cancer undergoing breast-conserving therapy. Breast 17, 64-70.
14. James, M. L., Lehman, M., Hider, P. N., Jeffery, M., Hickey, B. E., and Francis, D. P. (2010). Fraction size in radiation treatment for breast conservation in early breast cancer. Cochrane Database Syst. Rev. CD003860.
15. Matthews, J. H., Meeker, B. E., and Chapman, J. D. (1989). Response of human tumor cell lines in vitro to fractionated irradiation. Int. J. Radiat. Oncol. Biol. Phys. 16, 133-138.
16. Owen, J. R., Ashton, A., Bliss, J. M., Homewood, J., Harper, C., Hanson, J., Haviland, J., Bentzen, S. M., and Yarnold, J. R. (2006). Effect of radiotherapy fraction size on tumour control in patients with early-stage breast cancer after local tumour excision: long-term results of a randomised trial. Lancet Oncol. 7, 467-471.
17. Poortmans, P. M., Collette, L., Bartelink, H., Struikmans, H., Van Den Bogaert, W. F., Fourquet, A., Jager, J. J., Hoogenraad, W., Muller, R. P., Dubois, J. B., Bolla, M., Van Der Hulst, M., Warlam-Rodenhuis, C. C., Pierart, M., and Horiot, J. C. (2008). The addition of a boost dose on the primary tumour bed after lumpectomy in breast conserving treatment for breast cancer. A summary of the results of EORTC 22881-10882 "boost versus no boost" trial. Cancer Radiother. 12, 565-570.
18. Rosenstein, B. S., Lymberis, S. C., and Formenti, S. C. (2004). Biologic comparison of partial breast irradiation protocols. Int. J. Radiat. Oncol. Biol. Phys. 60, 1393-1404.
19. Shafiq, J., Delaney, G., and Barton, M. B. (2007). An evidence-based estimation of local control and survival benefit of radiotherapy for breast cancer. Radiother. Oncol. 84, 11-17.
20. Smith, B. D., Arthur, D. W., Buchholz, T. A., Haffty, B. G., Hahn, C. A., Hardenbergh, P. H., Julian, T. B., Marks, L. B., Todor, D. A., Vicini, F. A., Whelan, T. J., White, J., Wo, J. Y., and Harris, J. R. (2009). Accelerated partial breast irradiation consensus statement from the American Society for Radiation Oncology (ASTRO). Int. J. Radiat. Oncol. Biol. Phys. 74, 987-1001.
21. Stanton, P. D., Cooke, T. G., Forster, G., Smith, D., and Going, J. J. (1996). Cell kinetics in vivo of human breast cancer. Br. J. Surg. 83, 98-102.
22. Steel, G. G., Deacon, J. M., Duchesne, G. M., Horwich, A., Kelland, L. R., and Peacock, J. H. (1987). The dose-rate effect in human tumour cells. Radiother. Oncol. 9, 299-310.
23. Thames, H. D., Bentzen, S. M., Turesson, I., Overgaard, M., and Van Den Bogaert, W. (1990). Time-dose factors in radiotherapy: a review of the human data. Radiother. Oncol. 19, 219-235.
24. Travis, E. L., and Tucker, S. L. (1987). Isoeffect models and fractionated radiation therapy. Int. J. Radiat. Oncol. Biol. Phys. 13, 283-287.
25. Turesson, I., and Thames, H. D. (1989). Repair capacity and kinetics of human skin during fractionated radiotherapy: erythema, desquamation, and telangiectasia after 3 and 5 year's follow-up. Radiother. Oncol. 15, 169-188.
26. van der Laan, H. P., Dolsma, W. V., Maduro, J. H., Korevaar, E. W., Hollander, M., and Langendijk, J. A. (2007). Three-dimensional conformal simultaneously integrated boost technique for breast-conserving radiotherapy. Int. J. Radiat. Oncol. Biol. Phys. 68, 1018-1023.
27. Whelan, T., Mackenzie, R., Julian, J., Levine, M., Shelley, W., Grimard, L., Lada, B., Lukka, H., Perera, F., Fyles, A., Laukkanen, E., Gulavita, S., Benk, V., and Szechtman, B. (2002). Randomized trial of breast irradiation schedules after lumpectomy for women with lymph node-negative breast cancer. J. Natl. Cancer Inst. 94, 1143-1150.
28. Whelan, T. J., Pignol, J. P., Levine, M. N., Julian, J. A., Mackenzie, R., Parpia, S., Shelley, W., Grimard, L., Bowen, J., Lukka, H., Perera, F., Fyles, A., Schneider, K., Gulavita, S., and Freeman, C. (2010). Long-term results of hypofractionated radiation therapy for breast cancer. N. Engl. J. Med. 362, 513-520.
29. Yamada, Y., Ackerman, I., Franssen, E., Mackenzie, R. G., and Thomas, G. (1999). Does the dose fractionation schedule influence local control of adjuvant radiotherapy for early stage breast cancer? Int. J. Radiat. Oncol. Biol. Phys. 44, 99-104.
30. Yarnold, J., Ashton, A., Bliss, J., Homewood, J., Harper, C., Hanson, J., Haviland, J., Bentzen, S., and Owen, R. (2005). Fractionation sensitivity and dose response of late adverse effects in the breast after radiotherapy for early breast cancer: long-term results of a randomised trial. Radiother. Oncol. 75, 9-17.